A detailed history of Grassi Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Grassi Investment Management holds 4,400 shares of AMGN stock, worth $1.27 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,400
Previous 8,030 45.21%
Holding current value
$1.27 Million
Previous $2.51 Million 43.48%
% of portfolio
0.12%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$309.38 - $337.38 $1.12 Million - $1.22 Million
-3,630 Reduced 45.21%
4,400 $1.42 Million
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $2.16 Million - $2.61 Million
8,030 New
8,030 $2.28 Million
Q1 2019

Apr 10, 2019

SELL
$180.87 - $203.88 $6.88 Million - $7.76 Million
-38,050 Closed
0 $0
Q4 2018

Jan 10, 2019

BUY
$178.4 - $208.25 $6.61 Million - $7.71 Million
37,025 Added 3612.2%
38,050 $7.41 Million
Q3 2018

Oct 12, 2018

BUY
$185.29 - $208.89 $189,922 - $214,112
1,025 New
1,025 $212,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Grassi Investment Management Portfolio

Follow Grassi Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.